Mises à jour impartiales et pratiques en psychopharmacologie
Restez à jour avec des contenus pratiques en psychopharmacologie en audio, vidéo et texte, avec des crédits CME.
Recevez les mises à jour en psychopharmacologie dans votre boîte de réception
TENDANCES AU PSYCHOPHARMACOLOGY INSTITUTE
Quick Takes
Les GLP-1 dans la schizophrénie : faut-il prescrire le sémaglutide pour la prise en charge métabolique ?
Augmentation versus changement d’antidépresseur dans la dépression gériatrique : principaux résultats de l’essai OPTIMUM
Changement d’antipsychotiques oraux : six stratégies et conseils pratiques
Déclin rénal lié au lithium : les inhibiteurs de SGLT2 peuvent-ils aider ?
Schizophrénie résistante au traitement : quelles options lorsque la clozapine n’est pas envisageable ?
Tout voir
Brain Guides
Guide sur la trazodone : pharmacologie, indications, recommandations posologiques et effets indésirables
Guide sur la buspirone : pharmacologie, indications, recommandations posologiques et effets indésirables
Effets indésirables gastro-intestinaux des antidépresseurs : mécanismes, comparaison et stratégies de prise en charge
Dextromethorphan/bupropion : pharmacologie, indications, recommandations posologiques et effets indésirables
Antidépresseurs tricycliques en psychiatrie : partie 1 – sélection et prescription
Tout voir
Video Lectures
Maladie hépatique : buprénorphine, méthadone et agents d’aide au sevrage tabagique
Augmentation glutamatergique dans le TOC : mémantine, riluzole, lamotrigine et autres agents
Lamotrigine pour la dépression bipolaire
Antipsychotiques dans le PTSD avec symptômes psychotiques : rispéridone, aripiprazole et quétiapine
Effets secondaires sexuels des antipsychotiques, des thymorégulateurs et des benzodiazépines
Tout voir
PUBLICATIONS RÉCENTES
Quick Take Vol. 91
Effets indésirables cardiaques des médicaments psychiatriques
Actualisation d’août 2026 : centanafadine, oveporexton, et nouvelles recommandations sur le TOC, le lithium et l’insomnie
Quick Take Vol. 90
Pharmacothérapie de l’insomnie chronique : un guide pratique
Hyponatrémie induite par les antidépresseurs : mécanismes, risques, diagnostic et prise en charge
Explorez notre vaste bibliothèque de vidéos, de résumés de recherche et d’entretiens avec des experts.
CME Information
Physicians – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing professionals – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour.
All of our content is psychopharmacology, so the pharmacology hours shown on your certificate match the credits awarded for that activity. Your certificate states them on their own line, separately from the credit designation statement.
This applies to APRN pharmacology renewal as well. Boards of nursing define pharmacology CE in their own way, so please confirm with your board that this is the documentation they expect.
Physician assistants – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The NCCPA accepts AMA PRA Category 1 Credit™ from providers accredited by the ACCME toward PA certification maintenance. Requirements are set by the NCCPA, so please confirm with them what your current cycle requires.
Physicians outside the United States – CME Accreditation Statement

AMA PRA Category 1 Credit™ may be awarded to any physician, whether or not they are licensed in the United States. The requirements are the same.
The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu.
Whether these credits count toward your own national continuing education requirement is decided by your national medical chamber or society, and the rules differ from country to country. We recommend confirming with them before relying on the credits for a licensing or recertification requirement.
Self Assessment for MOC – Accreditation Statement
- Psychopharmacology Institute Self-Assessment Program 2026
Dates: April 1, 2026 – April 1, 2029
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2026 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment Program 2025
Dates: April 1, 2025 – April 1, 2028
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment Program 2024
Dates: April 1, 2024 – April 1, 2027
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

Vous vous sentez perdu au début de votre résidence en psychiatrie ?
Accédez à TOUS nos produits GRATUITEMENT pendant 3 mois !
